American Century Companies Inc. Lowers Stock Position in Pediatrix Medical Group, Inc. $MD

Key Points

• American Century Companies Inc. reduced its holdings in Pediatrix Medical Group, Inc. by 13.7%, selling 237,485 shares, and now owns about 1.75% of the company valued at $21.76 million.
• Several institutional investors, including Principal Financial Group and GAMMA Investing LLC, have recently increased their stakes in Pediatrix Medical Group, highlighting a growing interest in the company among hedge funds and institutional investors.
• Pediatrix Medical Group reported a quarterly earnings per share (EPS) of $0.53, exceeding estimates and showing a year-over-year revenue decline of 7.1% despite achieving better-than-expected results.

American Century Companies Inc. lowered its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 13.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,501,838 shares of the company's stock after selling 237,485 shares during the period. American Century Companies Inc. owned about 1.75% of Pediatrix Medical Group worth $21,762,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC lifted its position in shares of Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after buying an additional 1,765 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after acquiring an additional 5,104 shares during the period. Squarepoint Ops LLC purchased a new position in Pediatrix Medical Group during the fourth quarter worth approximately $132,000. Sherbrooke Park Advisers LLC purchased a new stake in Pediatrix Medical Group during the fourth quarter worth about $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in shares of Pediatrix Medical Group during the first quarter worth $159,000. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Performance

NYSE:MD traded down $0.05 during mid-day trading on Tuesday, hitting $17.01. 811,712 shares of the stock were exchanged, compared to its average volume of 911,081. The firm's 50-day simple moving average is $13.90 and its 200 day simple moving average is $13.98. The stock has a market capitalization of $1.48 billion, a price-to-earnings ratio of 13.19 and a beta of 1.21. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. Pediatrix Medical Group, Inc. has a fifty-two week low of $10.06 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. The firm had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company's quarterly revenue was down 7.1% on a year-over-year basis. During the same quarter last year, the business posted $0.34 earnings per share. As a group, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on MD shares. Zacks Research raised Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. Macquarie upped their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Finally, UBS Group lifted their price target on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.